What is the current price and volume for 4564.T stock today?

On 20 Feb 2026 intraday, 4564.T stock trades at JPY 21.00 with volume **34,217,200** and a day range of **JPY 21.00–22.00** on the JPX exchange, marking it among the session’s most active names.

What are the main catalysts for 4564.T stock performance?

Pipeline milestones for S‑588410 (Phase III) and OTS167, plus quarterly earnings and trial updates, are the primary catalysts that drive sharp intraday volume and price moves in 4564.T stock.

What rating and forecast does Meyka AI assign to 4564.T stock?

Meyka AI rates 4564.T with a score out of 100 at **69.18 (Grade B, HOLD)** and its model projects a yearly price of **JPY 18.02**, implying **-14.18%** vs the current JPY 21.00; forecasts are projections, not guarantees.

Is 4564.T stock overvalued based on fundamentals?

Relative valuation shows a high P/S **9.20** and PB **3.54** versus sector medians, while EPS is negative **-2.83**, indicating the stock trades at a premium to fundamentals and depends on successful clinical outcomes.

JP Stocks

4564.T OncoTherapy Science (JPX) at JPY 21.00 intraday: 34.22M shares traded signals active interest

ByHuzaifa Zahoor February 20, 2026February 20, 2026

The 4564.T stock of OncoTherapy Science, Inc. is trading at JPY 21.00 intraday on JPX on 20 Feb 2026 with 34,217,200 shares changing hands, ranking it among the most active names on the session. Volume has driven a move between a day low JPY 21.00 and day high JPY 22.00, while the year range sits at JPY 19.00–35.00. Market attention is tied to the company’s late‑stage vaccine program and ongoing small‑molecule oncology trials, which are the primary catalysts moving price and liquidity today.